T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Trends in immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.it.2009.09.003PMID 19879804PMCID PMC4126423
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extracellular mutant SOD1 induces microglial‐mediated motoneuron injury

  2010cited by this paper
• Microglial physiology: unique stimuli, specialized responses.

  2009cited by this paper
• Nitrated α-Synuclein-Induced Alterations in Microglial Immunity Are Regulated by CD4+ T Cell Subsets1

  2009cited by this paper
• Neuronal regulation of immune responses in the central nervous system.

  2009cited by this paper
• α-Synuclein and neuronal cell death

  2009cited by this paper
• Regulatory Properties of Copolymer I in Th17 Differentiation by Altering STAT3 Phosphorylation1

  2009cited by this paper
• Distribution of the Immune Inhibitory Molecules CD200 and CD200R in the Normal Central Nervous System and Multiple Sclerosis Lesions Suggests Neuron-Glia and Glia-Glia Interactions

  2009cited by this paper
• Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta.

  2009cited by this paper
• Neuro-immune crosstalk in CNS diseases.

  2009cited by this paper
• Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1β in human monocytes and multiple sclerosis

  2009cited by this paper
• Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy.

  2008cited by this paper
• T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS

  2008cited by this paper
• Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons

  2008cited by this paper
• CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS

  2008cited by this paper
• Neuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration

  2008cited by this paper
• Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice

  2008cited by this paper
• Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.

  2008influential reference
• Macrophage Polarization in Bacterial Infections

  2008cited by this paper
• Human Anti-Inflammatory Macrophages Induce Foxp3+GITR+CD25+ Regulatory T Cells, Which Suppress via Membrane-Bound TGFβ-11

  2008cited by this paper
• Macrophage activation and polarization.

  2008cited by this paper
• Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T‐cell responses

  2008cited by this paper
• Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease.

  2007cited by this paper
• CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages

  2007cited by this paper
• Mutant SOD1G93A microglia are more neurotoxic relative to wild‐type microglia

  2007cited by this paper
• Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons.

  2007cited by this paper
• Alternative Activation Is an Innate Response to Injury That Requires CD4+ T Cells to be Sustained during Chronic Infection1

  2007cited by this paper
• Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

  2007cited by this paper
• Wild‐type superoxide dismutase acquires binding and toxic properties of ALS‐linked mutant forms through oxidation

  2007cited by this paper
• Involvement of Interferon-γ in Microglial-Mediated Loss of Dopaminergic Neurons

  2007cited by this paper
• Chemokines in the MPTP model of Parkinson's disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration.

  2007influential reference
• Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis

  2007cited by this paper
• Controlled autoimmunity in CNS maintenance and repair

  2007cited by this paper
• CD200–CD200R Regulation of Microglia Activation in the Pathogenesis of Parkinson’s Disease

  2007cited by this paper
• Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis

  2006cited by this paper
• Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia

  2006cited by this paper
• Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4(+) T cells.

  2006cited by this paper
• Endogenous T lymphocytes and microglial reactivity in the axotomized facial motor nucleus of mice: effect of genetic background and the RAG2 gene.

  2006cited by this paper
• Review ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors

  2006cited by this paper
• Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE

  2006cited by this paper
• CD4(+) T cell-mediated facial motoneuron survival after injury: Distribution pattern of cell death and rescue throughout the extent of the facial motor nucleus.

  2006cited by this paper
• ALS: a disease of motor neurons and their nonneuronal neighbors.

  2006cited by this paper
• The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS.

  2006cited by this paper
• CNS immune privilege: hiding in plain sight

  2006cited by this paper
• Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis

  2006cited by this paper
• Protective effects of an anti‐inflammatory cytokine, interleukin‐4, on motoneuron toxicity induced by activated microglia

  2006influential reference
• Microglial phenotype: is the commitment reversible?

  2006influential reference
• Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates

  2005influential reference
• Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases.

  2005cited by this paper
• Brain-derived neurotrophic factor supports facial motoneuron survival after facial nerve transection in immunodeficient mice.

  2005cited by this paper
• Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

  2005cited by this paper
• Oxidative stress and inflammation in Parkinson's disease: is there a causal link?

  2005cited by this paper
• Vaccination with autoantigen protects against aggregated β‐amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cells

  2004cited by this paper
• Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system.

  2004cited by this paper
• Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications

  2004cited by this paper
• Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

  2004cited by this paper
• Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease.

  2004cited by this paper
• Chemokines and Glial Cells: A Complex Network in the Central Nervous System

  2004cited by this paper
• Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications.

  2004cited by this paper
• Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria.

  2004cited by this paper
• Expression of the histocompatibility glycoprotein HLA-DR in neurological disease

  2004cited by this paper
• Activated Microglia Initiate Motor Neuron Injury by a Nitric Oxide and Glutamate‐Mediated Mechanism

  2004cited by this paper
• Presence of dendritic cells, MCP‐1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue

  2004cited by this paper
• CD4-Positive T Cell-Mediated Neuroprotection Requires Dual Compartment Antigen Presentation

  2004cited by this paper
• Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice

  2003cited by this paper
• Vulnerability of Human Neurons to T Cell-Mediated Cytotoxicity1

  2003cited by this paper
• CD4+ T, but not CD8+ or B, lymphocytes mediate facial motoneuron survival after facial nerve transection.

  2003cited by this paper
• Parkinson's Disease Mechanisms and Models

  2003cited by this paper
• NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

  2003influential reference
• Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.

  2002cited by this paper
• Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)

  2002cited by this paper
• Neuroprotective autoimmunity: Naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system

  2002cited by this paper
• Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: No requirement for proapoptotic interleukin‐1β in neurodegeneration

  2001cited by this paper
• Immune reactivity in a mouse model of familial ALS correlates with disease progression

  2001cited by this paper
• Absence of Monocyte Chemoattractant Protein 1 in Mice Leads to Decreased Local Macrophage Recruitment and Antigen-Specific T Helper Cell Type 1 Immune Response in Experimental Autoimmune Encephalomyelitis

  2001influential reference
• Microglial activation and dopaminergic cell injury

  2001cited by this paper
• From charcot to lou gehrig: deciphering selective motor neuron death in als

  2001cited by this paper
• Glutamatergic influences on the basal ganglia.

  2001cited by this paper
• Microglial Activation and Dopaminergic Cell Injury: An In Vitro Model Relevant to Parkinson's Disease

  2001cited by this paper
• iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis.

  2000cited by this paper
• Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.

  2000cited by this paper
• Exacerbation of Facial Motoneuron Loss after Facial Nerve Transection in Severe Combined Immunodeficient (scid) Mice

  1999cited by this paper
• Inducible Nitric Oxide Synthase Up‐Regulation in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis

  1999cited by this paper
• FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.

  1999cited by this paper
• Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

  1999influential reference
• Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine exposure

  1999cited by this paper
• FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces, In Vitro, Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells

  1999cited by this paper
• Distinct Mechanisms Underlie Neurotoxin-Mediated Cell Death in Cultured Dopaminergic Neurons

  1999cited by this paper
• Immune Surveillance in the Injured Nervous System: T-Lymphocytes Invade the Axotomized Mouse Facial Motor Nucleus and Aggregate around Sites of Neuronal Degeneration

  1998cited by this paper
• Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.

  1998cited by this paper
• Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

  1997cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997cited by this paper
• An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.

  1995cited by this paper
• Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.

  1995cited by this paper
• Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

  1994cited by this paper
• Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis.

  1993cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

  1993cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

  1993cited by this paper
• IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis.

  1990cited by this paper
• IV. MPTP, MPP+ and mitochondrial function

  1987cited by this paper

• The role of miRNAs in the development of Super-Tregs as a potential therapy for neurodegenerative diseases.

  2026cites this paper
• From pathogenesis to therapy: the emerging role of regulatory T cells in amyotrophic lateral sclerosis

  2026cites this paper
• CRMP2 phosphorylation regulates polarization and spinal infiltration of CD4+ T lymphocytes, inhibits spinal glial activation, and arthritic pain

  2025cites this paper
• The metabolic intersection between immunosenescence and neuroinflammation in amyotrophic lateral sclerosis

  2025cites this paper
• Морфологічна характеристика міокарда на фоні зміни вмісту імунних клітин у головному мозку при змодельованому паркінсонізмі в мишей різних ліній

  2025cites this paper
• Neutrophil-to-lymphocyte ratio in aging: Trends and clinical implications.

  2025cites this paper
• Inhibiting Immune Crosstalk by Modulation of the Intracellular Function and Extracellular Environment of Diseased Microglia to Boost Parkinson's Disease Therapy.

  2025cites this paper
• The Role of T-lymphocytes in Central Nervous System Diseases.

  2024cites this paper
• Neuroprotective and immunomodulatory effects of superoxide dismutase on SH-SY5Y neuroblastoma cells and RAW264.7 macrophages

  2024cites this paper
• Indoleamine 2,3-dioxygenase (IDO1) - Can dendritic cells and monocytes expressing this moonlight enzyme change the phase of Parkinson's Disease?

  2024cites this paper
• The Current Landscape of Hypotheses Describing the Contribution of CD4+ Heterogeneous Populations to ALS

  2024cites this paper
• Circulating Levels of T-Cell Traits and the Risk of Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study

  2024cites this paper
• Microglial senescence in neurodegeneration: Insights, implications, and therapeutic opportunities

  2024cites this paper
• THE STATE OF THE IMMUNE AND ENDOCRINE SYSTEMS IN MICE WITH DIFFERENT HAPLOTYPE H-2 AND ITS POTENTIAL CONNECTION WITH EXPERIMENTAL PARKINSONISM MANIFESTATIONS

  2024cites this paper
• Comprehensive Analysis of the miRNA-mRNA Pathological Regulatory Network of Intestinal CD4 + T Cells in Parkinson’s Disease

  2023influential citation
• Regulatory T cells promote functional recovery after spinal cord injury by alleviating microglia inflammation via STAT3 inhibition

  2023cites this paper
• Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease

  2023cites this paper
• Changes in the number of macrophages, T-lymphocytes, activity of antioxidant enzymes in the brain, behavior and structure of the central nervous system neurons in adult and aging mice of different strains with the MPTP-induced model of parkinsonism

  2023cites this paper
• Alpha-Synuclein-Specific Regulatory T Cells Ameliorate Parkinson’s Disease Progression in Mice

  2023cites this paper
• Better Outcomes with Intranigral versus Intrastriatal Cell Transplantation: Relevance for Parkinson’s Disease

  2022cites this paper
• Blocking Immune Cell infiltration of the Central Nervous System to Tame Neuroinflammation in Amyotrophic Lateral Sclerosis.

  2022cites this paper
• Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson's disease.Prevention of neuroinflammation in Parkinson's disease.

  2022cites this paper
• Protective Effect of CP690550 in MPTP-Induced Parkinson’s Like Behavioural, Biochemical and Histological Alterations in Mice

  2022cites this paper
• Dual Role of Lysophosphatidic Acid Receptor 2 (LPA2) in Amyotrophic Lateral Sclerosis

  2021cites this paper
• INTERPLAY BETWEEN IMMUNITY AND AMYOTROPHIC LATERAL SCLEROSIS: CLINICAL IMPACT.

  2021cites this paper
• T Cells: A Growing Universe of Roles in Neurodegenerative Diseases

  2021cites this paper
• Dopamine receptor D2 on CD4+ T cells is protective against neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.

  2021cites this paper
• Diverse functions and mechanisms of regulatory T cell in ischemic stroke.

  2021cites this paper
• Immune Response in Neurological Pathology: Emerging Role of Central and Peripheral Immune Crosstalk

  2021cites this paper
• The role of immune cells in the course of Parkinson's disease.

  2021cites this paper
• Normal aging, motor neurone disease, and Alzheimer’s disease are characterized by cortical changes in inflammatory cytokines

  2021cites this paper
• Gateway reflexes, neuronal circuits that regulate the gateways for autoreactive T cells in organs that have blood barriers.

  2021cites this paper
• Potential protective role of astrocytes in the pathogenesis of astrocyte-mediated synaptic plasticity of Parkinson's disease.

  2021cites this paper
• Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson’s disease

  2021cites this paper
• Tanshinone IIA: A phytochemical as a promising drug candidate for neurodegenerative diseases.

  2021cites this paper
• Epigenetic Regulation of Neuroinflammation in Parkinson’s Disease

  2021cites this paper
• Potential Common Genetic Risks of Sporadic Parkinson’s Disease and Amyotrophic Lateral Sclerosis in the Han Population of Mainland China

  2021cites this paper
• Neurons and Glia Interplay in α-Synucleinopathies

  2021cites this paper
• Neurovascular Inflammaging in Health and Disease

  2020cites this paper
• Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders

  2020influential citation
• Mechanisms of alpha-synuclein toxicity: An update and outlook.

  2020cites this paper
• Immunosuppressive Functions of M2 Macrophages Derived from iPSCs of Patients with ALS and Healthy Controls

  2020cites this paper
• Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis

  2020cites this paper
• Glial cells in intracerebral transplantation for Parkinson’s disease

  2020influential citation
• Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study)

  2020cites this paper
• Elevated acute phase proteins reflect peripheral inflammation and disease severity in patients with amyotrophic lateral sclerosis

  2020cites this paper
• T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson’s disease

  2020cites this paper
• A 20-Year Journey from Axonal Injury to Neurodegenerative Diseases and the Prospect of Immunotherapy for Combating Alzheimer’s Disease

  2020cites this paper
• Inflammatory and immune mechanisms underlying epileptogenesis and epilepsy: From pathogenesis to treatment target.

  2020cites this paper
• Neuroimmunity in amyotrophic lateral sclerosis: focus on microglia

  2020cites this paper
• Genetic insights in canine degenerative myelopathy Genetische inzichten in degeneratieve myelopathie bij honden

  2020influential citation
• Effects of anesthetic method on inflammatory response in patients with Parkinson’s disease: a randomized controlled study

  2020cites this paper
• Gateway reflex: Local neuroimmune interactions that regulate blood vessels.

  2019cites this paper
• Association between ALS and retroviruses: evidence from bioinformatics analysis

  2019cites this paper
• α-Synuclein and Glia in Parkinson’s Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System?

  2019cites this paper
• A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases

  2019cites this paper
• Antioxidant and Anti-inflammatory Mechanisms of Neuroprotection by Ursolic Acid: Addressing Brain Injury, Cerebral Ischemia, Cognition Deficit, Anxiety, and Depression

  2019cites this paper
• Significant roles of neuroinflammation in Parkinson’s disease: therapeutic targets for PD prevention

  2019cites this paper
• Microglial Phagocytosis of Neurons: Diminishing Neuronal Loss in Traumatic, Infectious, Inflammatory, and Autoimmune CNS Disorders

  2019cites this paper
• A secret that underlies Parkinson's disease: The damaging cycle.

  2019cites this paper
• Calcium(II) oscillations to glucose: An astrocyte relation.

  2019cites this paper
• PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model

  2019cites this paper
• Predicting disease specific spinal motor neurons and glia in sporadic ALS.

  2019cites this paper
• The Role of Th17 Cells in Immunopathogenesis of Neuroinflammatory Disorders

  2019cites this paper
• Neural stimulations regulate the infiltration of immune cells into the CNS

  2019cites this paper
• IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.

  2019cites this paper
• Microglial overexpression of fALS-linked mutant SOD1 induces SOD1 processing impairment, activation and neurotoxicity and is counteracted by the autophagy inducer trehalose.

  2018cites this paper
• Counteracting roles of MHCI and CD8+ T cells in the peripheral and central nervous system of ALS SOD1G93A mice

  2018cites this paper
• Immunization with α‐synuclein/Grp94 reshapes peripheral immunity and suppresses microgliosis in a chronic Parkinsonism model

  2018cites this paper
• Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis

  2018influential citation
• Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse Model

  2018cites this paper
• Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease

  2018cites this paper
• The Role of Regulatory T Lymphocytes in Amyotrophic Lateral Sclerosis.

  2018cites this paper
• RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue

  2018cites this paper
• Kv1.3 In Microglia: Neuroinflammatory Determinant and Promising Pharmaceutical Target

  2018cites this paper
• Gateway Reflex: A Neuro-Immune Crosstalk for Organ-Specific Disease Development

  2018cites this paper
• Gateway reflex: neural activation-mediated immune cell gateways in the central nervous system

  2018cites this paper
• T Cell Mediated Cytotoxicity in the MPTP Mouse Model of Parkinson's Disease

  2018cites this paper
• Modulation of the inflammatory response in amyotrophic lateral sclerosis

  2018cites this paper
• Targeting toll‐like receptor 4 signalling pathways: can therapeutics pay the toll for hypertension?

  2018cites this paper
• Curative Anti-Inflammatory Properties of Chinese Optimized Yinxieling Formula in Models of Parkinson's Disease

  2018cites this paper
• Nano‐ and neurotoxicology: An emerging discipline

  2018cites this paper
• Chapter 2 Neuroinflammation and Neurodegeneration

  2018cites this paper
• Aging modulates microglia phenotypes in neuroinflammation of MPTP‐PD mice

  2018cites this paper
• An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosis

  2018cites this paper
• P38 Mitogen-activated Protein Kinase and Parkinson’s Disease

  2018cites this paper
• An Inflammation-Centric View of Neurological Disease: Beyond the Neuron

  2018cites this paper
• Ultra-micronized Palmitoylethanolamide: An Efficacious Adjuvant Therapy for Parkinson's Disease.

  2017cites this paper
• Brain micro-inflammation at specific vessels dysregulates organ-homeostasis via the activation of a new neural circuit

  2017cites this paper
• ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity.

  2017cites this paper
• Optineurin in amyotrophic lateral sclerosis: Multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms.

  2017cites this paper
• Neurons other than motor neurons in motor neuron disease.

  2017cites this paper
• Neurotransmission systems in Parkinson’s disease

  2017cites this paper
• The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma

  2017cites this paper
• The role of Th17 cells in auto-inflammatory neurological disorders.

  2017cites this paper
• Brainstem cytokine changes in healthy ageing and Motor Neurone Disease.

  2017cites this paper
• The interplay between Angiotensin II, TLR4 and hypertension.

  2017cites this paper
• Peripheral Lymphocyte Subsets as a Marker of Parkinson’s Disease in a Chinese Population

  2017cites this paper
• Monocytes of patients with amyotrophic lateral sclerosis linked to gene mutations display altered TDP‐43 subcellular distribution

  2017cites this paper
• Amyotrophic Lateral Sclerosis, a Multisystem Pathology: Insights into the Role of TNFα

  2017cites this paper